:

Yu-Dan Cao1, Hong-Wei Sun1, Tian-Ci Li1

  • 1Department of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Frontiers in oncology
|November 10, 2025
PubMed
概括

使用蛋白衍生性中性粒细胞与淋巴细胞比率 (Alb-dNLR) 评分的新型诺基图改善了非转移性结直肠癌 (CRC) 的预后准确性. 这个工具比传统的TNM分阶段系统提供了更个性化的预测.